Nanoform Finland Oyj (HEL:NANOFH)

Market Cap	42.58M -55.6%
Revenue (ttm)	5.02M +37.1%
Net Income	-17.90M
EPS	-0.21
Shares Out	85.67M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25
Average Volume	296,937
Open	0.4975
Previous Close	0.4970
Day's Range	0.4755 - 0.4995
52-Week Range	0.3770 - 1.3820
Beta	0.56
RSI	38.12
Earnings Date	May 19, 2026

About Nanoform Finland Oyj

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and flexible dosage forms of nanoformed drug substances. It also offers STARMAP,...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 171
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: NANOFH

Financial Performance

In 2025, Nanoform Finland Oyj's revenue was 5.02 million, an increase of 37.10% compared to the previous year's 3.66 million. Losses were -17.90 million, -23.60% less than in 2024.